Business
WILLOW SIGNS MASTER SERVICES AGREEMENT WITH INNOVATIVE BIOTECH COMPANY TO DEVELOP INGREDIENTS FOR AGE-RELATED DISEASES
WILLOW SIGNS MASTER SERVICES AGREEMENT WITH INNOVATIVE BIOTECH COMPANY TO DEVELOP INGREDIENTS FOR...
About this update from Atlas Energy Corp.
[{"type":"text","content":"\n \n \n \n WILLOW SIGNS MASTER SERVICES AGREEMENT WITH INNOVATIVE BIOTECH COMPANY TO DEVELOP INGREDIENTS FOR AGE-RELATED DISEASES\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n.prntaj{\nTEXT-ALIGN: JUSTIFY\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n Biotech partner recognizes strength of Willow's first in class FutureGrown\n \n ™\n \n technology platform for producing natural products\n \n \n \n \n Further expansion and diversification of Willow's product portfolio with collaboration revenue expected in 2023 and potential for near-term commercial product revenue\n \n \n \n \n \n MOUNTAIN VIEW, Calif.\n \n \n ,\n \n \n May 31, 2023\n \n \n /CNW/ - Willow Biosciences Inc. (\"\n \n Willow\n \n \") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consistent and sustainable functional ingredients announces execution of a Master Services Agreement (the \"MSA\") with an innovative biotech company focused on age-related diseases. Through this partnership, Willow will develop precision fermentation processes for a class of molecules with targets being developed as nutritional supplements for health and wellness and active pharmaceutical ingredients (APIs).\n \n \n \n \n \n \n \n \n \n Willow will use its FutureGrown™ technology platform and yeast-strain engineering expertise with the goal of developing a strain and process for production of the partner's ingredients. After a successful first phase, both parties anticipate the next steps will be a full process optimization program and entering into a commercial agreement for scaling up the targeted ingredients for use in consumer end-market products. Due to the disruptive potential nature of its targeted product applications, the partner's name and target molecules are not being disclosed at this time.\n \n \n \"We are delighted that our partner recognizes our expert strain engineering capabilities can help accelerate and support their product innovation needs to develop novel solutions...